BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China flag China · Delayed Price · Currency is CNY
59.10
-1.08 (-1.79%)
At close: Apr 29, 2026

SHA:688166 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
961.06765.35998.051,180336.84
Upgrade
Trading Asset Securities
--50.6250.120.76
Upgrade
Cash & Short-Term Investments
961.06765.351,0491,230337.6
Upgrade
Cash Growth
25.57%-27.02%-14.78%264.48%-35.02%
Upgrade
Accounts Receivable
330.02339.5308.88307.47373.85
Upgrade
Other Receivables
9.136.6619.9118.783.75
Upgrade
Receivables
339.14346.17328.79326.25377.59
Upgrade
Inventory
364.25364.61344.63280.35200.06
Upgrade
Prepaid Expenses
--3.655.834.48
Upgrade
Other Current Assets
124.04164.1411495.3973.27
Upgrade
Total Current Assets
1,7891,6401,8401,938993.01
Upgrade
Property, Plant & Equipment
2,7522,7052,4892,0761,378
Upgrade
Long-Term Investments
671.08437.06425.86399.33348.28
Upgrade
Goodwill
-3.127.57.57.5
Upgrade
Other Intangible Assets
79.5389.4893.6681.6480.84
Upgrade
Long-Term Accounts Receivable
4.12.1---
Upgrade
Long-Term Deferred Tax Assets
94.6862.242.2823.9419.86
Upgrade
Long-Term Deferred Charges
339.1957.4930.1826.8725.83
Upgrade
Other Long-Term Assets
95.42156.03104.09107.73115.86
Upgrade
Total Assets
5,8255,1535,0324,6612,970
Upgrade
Accounts Payable
185.89266228.18252.19211.89
Upgrade
Accrued Expenses
82.9772.0172.3169.0461.72
Upgrade
Short-Term Debt
110.11115.26156.87124.38257.05
Upgrade
Current Portion of Long-Term Debt
775.1516.96397.93313.8716.58
Upgrade
Current Portion of Leases
8.8313.6916.11.349.87
Upgrade
Current Income Taxes Payable
10.6116.6814.0414.973.69
Upgrade
Current Unearned Revenue
25.5628.022429.4920.33
Upgrade
Other Current Liabilities
81.2323.7612.816.261.93
Upgrade
Total Current Liabilities
1,2801,052922.25811.52583.07
Upgrade
Long-Term Debt
1,4901,5801,6151,576618.69
Upgrade
Long-Term Leases
10.2110.2121.016.010.22
Upgrade
Long-Term Unearned Revenue
167.5884.7126.252626
Upgrade
Other Long-Term Liabilities
30.3-29.82--
Upgrade
Total Liabilities
2,9792,7272,6142,4201,228
Upgrade
Common Stock
423.1422.47422.47422.47410
Upgrade
Additional Paid-In Capital
1,076982.361,0571,008738.94
Upgrade
Retained Earnings
1,0661,046897.66743.35555.05
Upgrade
Treasury Stock
-20.05-10.01---
Upgrade
Comprehensive Income & Other
-24.21-57.82-8.6417.77-25.8
Upgrade
Total Common Equity
2,5212,3832,3692,1921,678
Upgrade
Minority Interest
325.0142.7348.9750.0463.45
Upgrade
Shareholders' Equity
2,8462,4262,4182,2421,742
Upgrade
Total Liabilities & Equity
5,8255,1535,0324,6612,970
Upgrade
Total Debt
2,3952,2362,2072,022902.42
Upgrade
Net Cash (Debt)
-1,433-1,470-1,158-791.15-564.82
Upgrade
Net Cash Per Share
-3.42-3.50-2.75-1.91-1.39
Upgrade
Filing Date Shares Outstanding
422.54422.11422.1422.47410
Upgrade
Total Common Shares Outstanding
422.54422.11422.47422.47410
Upgrade
Working Capital
508.2587.89917.491,127409.94
Upgrade
Book Value Per Share
5.975.655.615.194.09
Upgrade
Tangible Book Value
2,4422,2912,2672,1031,590
Upgrade
Tangible Book Value Per Share
5.785.435.374.983.88
Upgrade
Buildings
745.28728.65261.26273.4104.72
Upgrade
Machinery
1,2711,122704.8318.41287.37
Upgrade
Construction In Progress
1,1871,1671,7361,6661,131
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.